{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:25:13Z","timestamp":1785209113104,"version":"3.55.0"},"reference-count":43,"publisher":"Texas Heart Institute Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Continuous-flow left ventricular assist devices (LVADs) are increasingly used as destination therapy. Although postimplantation stroke rates have been described in the context of bridge-to-transplant or mixed cohorts, stroke development is not well evaluated in patients who receive continuous-flow LVAD with a destination therapy indication. This report characterizes the stroke profile of a modern institutional cohort of patients undergoing destination therapy and evaluates their risk factors for stroke onset.<\/jats:p>\n<\/jats:sec>\n<jats:sec sec-type=\"methods\">\n<jats:title>Methods:<\/jats:title>\n<jats:p>Patients implanted with continuous-flow LVAD as destination therapy at the reporting institution between January 2010 and June 2020 were retrospectively reviewed and analyzed. Stroke was defined as any neurologic deficit caused by an abrupt disruption in cerebral blood flow that did not resolve within 24 hours and that was confirmed by imaging. Terminal outcomes of stroke development and death were assessed using a competing-risks model. Fine-Gray regression was used to evaluate potential predictors of stroke development.<\/jats:p>\n<\/jats:sec>\n<jats:sec sec-type=\"results\">\n<jats:title>Results:<\/jats:title>\n<jats:p>Patients who received continuous-flow LVAD (N = 311) were classified by device type: Heart-Mate II (Abbott; n = 97); HeartMate 3 (Abbott; n = 72); and HeartWare Ventricular Assist Device (Medtronic; n = 42). Thirty-five percent of patients (110\/311) developed postoperative atrial fibrillation (AF). Estimated stroke incidence was 15% at 1 year, 24% at 3 years, and 27% at 5 years. According to multivariable Fine-Gray regression, receiving a HeartMate 3 device (subdistribution hazard ratio [HR], 0.41 [95% CI, 0.19-0.90]; <jats:italic>P<\/jats:italic> = .03) and amiodarone at discharge (HR, 0.55 [95% CI, 0.33-0.94]; <jats:italic>P<\/jats:italic> = .03) were associated with lower stroke risk. Postoperative AF (HR, 1.68 [95% CI, 1.03-2.73]; <jats:italic>P<\/jats:italic> = .04) was associated with increased stroke risk.<\/jats:p>\n<\/jats:sec>\n<jats:sec sec-type=\"conclusions\">\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The HeartMate 3 was associated with decreased stroke rates, but risk remained high for patients who developed postoperative AF. Further investigation into protective strategies and use of amiodarone to treat AF after continuous-flow LVAD implantation is needed.<\/jats:p>\n<\/jats:sec>","DOI":"10.14503\/thij-23-8332","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:30:36Z","timestamp":1754353836000},"source":"Crossref","is-referenced-by-count":2,"title":["Risk Factors for Development of Stroke in Patients With Continuous-Flow Left Ventricular Assist Device Support as Destination Therapy"],"prefix":"10.14503","volume":"52","author":[{"given":"Ioana B.","family":"Florea","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia H.","family":"Bakir","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan O.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Schilling","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiovascular Diseases, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"},{"name":"Department of Pathology and Immunology, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Ewald","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiovascular Diseases, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer J.","family":"Melby","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Damiano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal D.","family":"Kotkar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad F.","family":"Masood","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5628","reference":[{"issue":"2","key":"b1","series-title":"Best Prac Res Clin Anaesthesiol","first-page":"105","article-title":"Pulsatile vs. continuous flow in ventricular assist device therapy","volume":"26","author":"Loor G","year":"2012","unstructured":"Loor G, Gonzalez-Stawinski G. Pulsatile vs. continuous flow in ventricular assist device therapy. Best Prac Res Clin Anaesthesiol. 2012;26(2):105-115. doi:10.1016\/j.bpa.2012.03.004"},{"issue":"10","key":"b2","series-title":"J Card Surg","first-page":"1062","article-title":"Comparison of heart transplant outcomes between recipients with pulsatile- vs continuous-flow LVAD","volume":"34","author":"Yazdchi F","year":"2019","unstructured":"Yazdchi F, Rajab TK, Rinewalt D, et al. Comparison of heart transplant outcomes between recipients with pulsatile- vs continuous-flow LVAD. J Card Surg. 2019;34(10):1062-1068. doi:10.1111\/jocs.14210"},{"issue":"1","key":"b3","series-title":"J Heart Lung Transplant","first-page":"1","article-title":"An early investigation of outcomes with the new 2018 donor heart allocation system in the United States","volume":"39","author":"Cogswell R","year":"2020","unstructured":"Cogswell R, John R, Estep JD, et al. An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. J Heart Lung Transplant. 2020;39(1):1-4. doi:10.1016\/j.healun.2019.11.002"},{"issue":"3","key":"b4","series-title":"Ann Thorac Surg","first-page":"778","article-title":"The Society of Thoracic Surgeons INTERMACS 2020 annual report","volume":"111","author":"Molina EJ","year":"2021","unstructured":"Molina EJ, Shah P, Kiernan MS, et al. The Society of Thoracic Surgeons INTERMACS 2020 annual report. Ann Thorac Surg. 2021;111(3):778-792. doi:10.1016\/j.athoracsur.2020.12.038"},{"issue":"1087","key":"b5","series-title":"Postgrad Med J","first-page":"271","article-title":"Left ventricular assist device: a bridge to transplant or destination therapy?","volume":"92","author":"Patel S","year":"2016","unstructured":"Patel S, Nicholson L, Cassidy CJ, Wong KYK. Left ventricular assist device: a bridge to transplant or destination therapy? Postgrad Med J. 2016;92(1087):271-281. doi:10.1136\/postgradmedj-2015-133718"},{"issue":"3","key":"b6","series-title":"Innovations (Phila)","first-page":"236","article-title":"Racial disparities and outcomes after left ventricular assist device implantation as bridge to transplantation or destination therapy","volume":"14","author":"Okoh AK","year":"2019","unstructured":"Okoh AK, Chan O, Schultheis M, et al. Racial disparities and outcomes after left ventricular assist device implantation as bridge to transplantation or destination therapy. Innovations (Phila). 2019;14(3):236-242. doi:10.1177\/1556984519836862"},{"issue":"9","key":"b7","series-title":"J Palliat Med","first-page":"977","article-title":"Palliative care interventions before left ventricular assist device implantation in both bridge to transplant and destination therapy","volume":"20","author":"Nakagawa S","year":"2017","unstructured":"Nakagawa S, Yuzefpolskaya M, Colombo PC, Naka Y, Blinderman CD. Palliative care interventions before left ventricular assist device implantation in both bridge to transplant and destination therapy. J Palliat Med. 2017;20(9):977-983. doi:10.1089\/jpm.2016.0568"},{"issue":"9","key":"b8","series-title":"J Palliat Med","first-page":"1284","article-title":"End of life with left ventricular assist device in both bridge to transplant and destination therapy","volume":"21","author":"Nakagawa S","year":"2018","unstructured":"Nakagawa S, Garan AR, Takayama H, et al. End of life with left ventricular assist device in both bridge to transplant and destination therapy. J Palliat Med. 2018;21(9):1284-1289. doi:10.1089\/jpm.2018.0112"},{"issue":"6","key":"b9","series-title":"Circ Heart Fail","first-page":"779","article-title":"Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices","volume":"4","author":"Suarez J","year":"2011","unstructured":"Suarez J, Patel CB, Felker GM, Becker R, Hernandez AF, Rogers JG. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail. 2011;4(6):779-784. doi:10.1161\/CIRCHEARTFAILURE.111.962613"},{"issue":"25","key":"b10","series-title":"Circulation","first-page":"3191","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson KD","year":"2012","unstructured":"Aaronson KD, Slaughter MS, Miller LW, et al; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191-3200. doi:10.1161\/CIRCULATIONAHA.111.058412"},{"issue":"6","key":"b11","series-title":"ASAIO J","first-page":"642","article-title":"Outcomes following left ventricular assist device exchange: focus on the impacts of device infection","volume":"67","author":"Yost G","year":"2021","unstructured":"Yost G, Coyle L, Gallagher C, Cotts W, Pappas P, Tatooles A. Outcomes following left ventricular assist device exchange: focus on the impacts of device infection. ASAIO J. 2021;67(6):642-649. doi:10.1097\/MAT.0000000000001287"},{"issue":"4","key":"b12","series-title":"Ann Thorac Surg","first-page":"1171","article-title":"Activation of endothelial and coagulation systems in left ventricular assist device recipients","volume":"88","author":"John R","year":"2009","unstructured":"John R, Panch S, Hrabe J, et al. Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg. 2009;88(4):1171-1179. doi:10.1016\/j.athoracsur.2009.06.095"},{"issue":"5","key":"b13","series-title":"Indian Heart J","first-page":"422","article-title":"Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: a nationwide study","volume":"71","author":"Thakkar S","year":"2019","unstructured":"Thakkar S, Rupareliya C, Doshi R. Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: a nationwide study. Indian Heart J. 2019;71(5):422-424. doi:10.1016\/j.ihj.2019.09.009"},{"issue":"10","key":"b14","series-title":"JACC Heart Fail","first-page":"703","article-title":"INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes","volume":"5","author":"Acharya D","year":"2017","unstructured":"Acharya D, Loyaga-Rendon R, Morgan CJ, et al. INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes. JACC Heart Fail. 2017;5(10):703-711. doi:10.1016\/j.jchf.2017.06.014"},{"issue":"1","key":"b15","series-title":"Ann Transl Med","first-page":"5","article-title":"Trends, predictors and outcomes of ischemic stroke and intracranial hemorrhage in patients with a left ventricular assist device","volume":"6","author":"Shahreyar M","year":"2018","unstructured":"Shahreyar M, Bob-Manuel T, Khouzam RN, et al. Trends, predictors and outcomes of ischemic stroke and intracranial hemorrhage in patients with a left ventricular assist device. Ann Transl Med. 2018;6(1):5. doi:10.21037\/atm.2017.12.23"},{"issue":"11","key":"b16","series-title":"Stroke","first-page":"2702","article-title":"Stroke risk and mortality in patients with ventricular assist devices","volume":"47","author":"Parikh NS","year":"2016","unstructured":"Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke risk and mortality in patients with ventricular assist devices. Stroke. 2016;47(11):2702-2706. doi:10.1161\/STROKEAHA.116.014049"},{"issue":"8","key":"b17","series-title":"J Heart Lung Transplant","first-page":"1003","article-title":"Outcomes after stroke complicating left ventricular assist device","volume":"35","author":"Willey JZ","year":"2016","unstructured":"Willey JZ, Gavalas MV, Trinh PN, et al. Outcomes after stroke complicating left ventricular assist device. J Heart Lung Transplant. 2016;35(8):1003-1009. doi:10.1016\/j.healun.2016.03.014"},{"issue":"2","key":"b18","series-title":"Stroke","first-page":"542","article-title":"Stroke incidence and impact of continuous-flow left ventricular assist devices on cerebrovascular physiology","volume":"50","author":"Cornwell WKIII","year":"2019","unstructured":"Cornwell WKIII, Ambardekar AV, Tran T, et al. Stroke incidence and impact of continuous-flow left ventricular assist devices on cerebrovascular physiology. Stroke. 2019;50(2):542-548. doi:10.1161\/STROKEAHA.118.022967"},{"issue":"4","key":"b19","series-title":"JAMA Cardiol","first-page":"411","article-title":"Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) randomized clinical trial","volume":"5","author":"Goldstein DJ","year":"2020","unstructured":"Goldstein DJ, Naka Y, Horstmanshof D, et al. Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) randomized clinical trial. JAMA Cardiol. 2020;5(4):411-419. doi:10.1001\/jamacardio.2019.5323"},{"key":"b20","series-title":"J Thromb Haemost","first-page":"S304","article-title":"Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview","volume":"13","author":"Bessissow A","year":"2015","unstructured":"Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost. 2015;13(suppl 1):S304-S312. doi:10.1111\/jth.12974"},{"issue":"20","key":"b21","series-title":"N Engl J Med","first-page":"1429","article-title":"Atrial arrhythmias after cardiothoracic surgery","volume":"336","author":"Ommen SR","year":"1997","unstructured":"Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997;336(20):1429-1434. doi:10.1056\/NEJM199705153362006"},{"issue":"2","key":"b22","series-title":"J Thorac Cardiovasc Surg","first-page":"559","article-title":"The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades","volume":"141","author":"Shen J","year":"2011","unstructured":"Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg. 2011;141(2):559-570. doi:10.1016\/j.jtcvs.2010.03.011"},{"issue":"4","key":"b23","series-title":"Eur J Cardiothorac Surg","first-page":"665","article-title":"Postoperative atrial fibrillation following cardiac surgery: a persistent complication","volume":"52","author":"Greenberg JW","year":"2017","unstructured":"Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52(4):665-672. doi:10.1093\/ejcts\/ezx039"},{"issue":"6","key":"b24","series-title":"Stroke","first-page":"1364","article-title":"Perioperative\/postoperative atrial fibrillation and risk of subsequent stroke and\/or mortality","volume":"50","author":"Lin MH","year":"2019","unstructured":"Lin MH, Kamel H, Singer DE, Wu YL, Lee M, Ovbiagele B. Perioperative\/postoperative atrial fibrillation and risk of subsequent stroke and\/or mortality. Stroke. 2019;50(6):1364-1371. doi:10.1161\/STROKEAHA.118.023921"},{"issue":"7","key":"b25","series-title":"Nat Rev Cardiol","first-page":"417","article-title":"Postoperative atrial fibrillation: mechanisms, manifestations and management","volume":"16","author":"Dobrev D","year":"2019","unstructured":"Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019;16(7):417-436. doi:10.1038\/s41569-019-0166-5"},{"issue":"3","key":"b26","series-title":"J Thorac Cardiovasc Surg","first-page":"e153","article-title":"2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures","volume":"148","author":"Frendl G","year":"2014","unstructured":"Frendl G, Sodickson AC, Chung MK, et al; American Association for Thoracic Surgery. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg. 2014;148(3):e153-e193. doi:10.1016\/j.jtcvs.2014.06.036"},{"issue":"6","key":"b27","series-title":"J Heart Lung Transplant","first-page":"673","article-title":"Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices","volume":"36","author":"Frontera JA","year":"2017","unstructured":"Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2017;36(6):673-683. doi:10.1016\/j.healun.2016.12.010"},{"issue":"10","key":"b28","series-title":"JACC Heart Fail","first-page":"818","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg JJ","year":"2015","unstructured":"Teuteberg JJ, Slaughter MS, Rogers JG, et al; ADVANCE Trial Investigators. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3(10):818-828. doi:10.1016\/j.jchf.2015.05.011"},{"issue":"6","key":"b29","series-title":"Ann Thorac Surg","first-page":"2161","article-title":"Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation","volume":"96","author":"Stulak JM","year":"2013","unstructured":"Stulak JM, Deo S, Schirger J, et al. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg. 2013;96(6):2161-2167. doi:10.1016\/j.athoracsur.2013.07.004"},{"issue":"14","key":"b30","series-title":"JAMA","first-page":"1720","article-title":"A multicenter risk index for atrial fibrillation after cardiac surgery","volume":"291","author":"Mathew JP","year":"2004","unstructured":"Mathew JP, Fontes ML, Tudor IC, et al; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720-1729. doi:10.1001\/jama.291.14.1720"},{"issue":"1","key":"b31","series-title":"Ann Thorac Surg","first-page":"41","article-title":"30 years of heart transplant: outcomes after mechanical circulatory support from a single center","volume":"113","author":"Finnan MJ","year":"2022","unstructured":"Finnan MJ, Bakir NH, Itoh A, et al. 30 years of heart transplant: outcomes after mechanical circulatory support from a single center. Ann Thorac Surg. 2022;113(1):41-48. doi:10.1016\/j.athoracsur.2021.01.064"},{"issue":"1","key":"b32","series-title":"J Thorac Cardiovasc Surg","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jtcvs.2020.06.142","article-title":"Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices","volume":"163","author":"Bakir NH","year":"2022","unstructured":"Bakir NH, Finnan MJ, MacGregor RM, et al. Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2022;163(1):124-134.e8. doi:10.1016\/j.jtcvs.2020.06.142."},{"issue":"2","key":"b33","series-title":"Circulation","first-page":"155","article-title":"Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 study","volume":"139","author":"Colombo PC","year":"2019","unstructured":"Colombo PC, Mehra MR, Goldstein DJ, et al. Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 study. Circulation. 2019;139(2):155-168. doi:10.1161\/CIRCULATIONAHA.118.037231"},{"issue":"5","key":"b34","series-title":"N Engl J Med","first-page":"440","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra MR","year":"2017","unstructured":"Mehra MR, Naka Y, Uriel N, et al; MOMENTUM 3 Investigators. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376(5):440-450. doi:10.1056\/NEJMoa1610426"},{"issue":"15","key":"b35","series-title":"N Engl J Med","first-page":"1386","article-title":"Two-year outcomes with a magnetically levitated cardiac pump in heart failure","volume":"378","author":"Mehra MR","year":"2018","unstructured":"Mehra MR, Goldstein DJ, Uriel N, et al; MOMENTUM 3 Investigators. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378(15):1386-1395. doi:10.1056\/NEJMoa1800866"},{"issue":"17","key":"b36","series-title":"N Engl J Med","first-page":"1618","article-title":"A fully magnetically levitated left ventricular assist device\u2014final report","volume":"380","author":"Mehra MR","year":"2019","unstructured":"Mehra MR, Uriel N, Naka Y, et al; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device\u2014final report. N Engl J Med. 2019;380(17):1618-1627. doi:10.1056\/NEJMoa1900486"},{"issue":"5","key":"b37","series-title":"N Engl J Med","first-page":"451","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers JG","year":"2017","unstructured":"Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376(5):451-460. doi:10.1056\/NEJMoa1602954"},{"issue":"5","key":"b38","series-title":"Stroke","first-page":"1197","article-title":"Cerebrovascular accidents during mechanical circulatory support: new predictors of ischemic and hemorrhagic strokes and outcome","volume":"49","author":"Izzy S","year":"2018","unstructured":"Izzy S, Rubin DB, Ahmed FS, et al. Cerebrovascular accidents during mechanical circulatory support: new predictors of ischemic and hemorrhagic strokes and outcome. Stroke. 2018;49(5):1197-1203. doi:10.1161\/STROKEAHA.117.020002"},{"key":"b39","series-title":"Recalls related to the HVAD system","author":"US Food & Drug Administration","unstructured":"US Food & Drug Administration. Recalls related to the HVAD system. Accessed July 28, 2025. https:\/\/www.fda.gov\/medical-devices\/cardiovascular-devices\/recalls-related-hvad-system"},{"issue":"7","key":"b40","series-title":"J Card Surg","first-page":"541","article-title":"Stroke after implantation of continuous flow left ventricular assist devices","volume":"34","author":"Tsiouris A","year":"2019","unstructured":"Tsiouris A, Heliopoulos I, Mikroulis D, Mitsias PD. Stroke after implantation of continuous flow left ventricular assist devices. J Card Surg. 2019;34(7):541-548. doi:10.1111\/jocs.14079"},{"issue":"5","key":"b41","series-title":"ASAIO J","first-page":"581","article-title":"Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist device","volume":"64","author":"Deshmukh A","year":"2018","unstructured":"Deshmukh A, Bhatia A, Anyanwu E, et al. Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist device. ASAIO J. 2018;64(5):581-585. doi:10.1097\/MAT.0000000000000763"},{"issue":"2","key":"b42","series-title":"J Thorac Cardiovasc Surg","first-page":"616","article-title":"Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: prescription patterns and 30-day outcomes in the United States and Canada","volume":"162","author":"Matos JD","year":"2021","unstructured":"Matos JD, McIlvaine S, Grau-Sepulveda M, et al. Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: prescription patterns and 30-day outcomes in the United States and Canada. J Thorac Cardiovasc Surg. 2021;162(2):616-624.e3. doi:10.1016\/j.jtcvs.2020.01.077"},{"issue":"7","key":"b43","series-title":"Ann Pharmacother","first-page":"830","article-title":"Management of atrial fibrillation following cardiac surgery: observational study and development of a standardized protocol","volume":"55","author":"Bruggmann C","year":"2021","unstructured":"Bruggmann C, Astaneh M, Lu H, et al. Management of atrial fibrillation following cardiac surgery: observational study and development of a standardized protocol. Ann Pharmacother. 2021;55(7):830-838. doi:10.1177\/1060028020973998"}],"container-title":["Texas Heart Institute Journal"],"original-title":[],"link":[{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/52\/2\/article-e238332.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/52\/2\/article-e238332.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/52\/2\/article-e238332.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:30:43Z","timestamp":1754353843000},"score":1,"resource":{"primary":{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/52\/2\/article-e238332.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":43,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.14503\/thij-23-8332","relation":{},"ISSN":["1526-6702","0730-2347"],"issn-type":[{"value":"1526-6702","type":"electronic"},{"value":"0730-2347","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}